Chapters

Transcript

Video

Case Presentation: Use of TORS for HPV-Positive Tonsil Squamous Cell Cancer

Name: Case Presentation: Use of TORS for HPV-Positive Tonsil Squamous Cell Cancer
Uploaded: 2016-12-22T00:00:00+00:00
Description: Otolaryngologist Carole Fakhry, M.D., discusses the case of a 52-year-old man presenting with a neck and tonsil mass. The patient is doing well after transoral robotic surgery (TORS) and neck dissection were performed, followed by radiation.

Otolaryngologist Carole Fakhry, M.D., discusses the case of a 52-year-old man presenting with a neck and tonsil mass. The patient is doing well after transoral robotic surgery (TORS) and neck dissection were performed, followed by radiation.

Created by

Related Presenters

Carole Fakhry, MD, MPH

Director, Johns Hopkins Head and Neck Cancer Center

Chief, Division of Head and Neck Surgery

Professor of Otolaryngology - Head and Neck Surgery

View full profile

FOUND IN

Oncology, Otolaryngology– Head and Neck Surgery

Welcome to
Clinical Connection

The content on this web site is intended for physicians. Patients, please visit hopkinsmedicine.org to learn more about Johns Hopkins patient care and services.

Physicians, discover the latest in biomedical research and clinical innovation from Johns Hopkins experts. Enjoy educational videos and engaging peer-to peer articles, and learn about clinical trials and CME courses available from our world-renowned institution.

For patients-please visit hopkinsmedicine.org to learn more about Johns Hopkins patient care and services.

Refer a Patient

International Patient Services

High-Value Health Care
Learn how we’re improving care and cutting costs for patients

Learn More

Related Videos

Video

Radiofrequency Ablation: A Treatment Option for Thyroid Nodules

Johns Hopkins endocrine surgeon and laryngologist Vaninder Dhillon describes radiofrequency ablation (RFA), the minimally invasive treatment option for thyroid nodules.

Video

Climate Change, the Environment and Rhinologic Disease

Johns Hopkins rhinologist Jean Kim recaps recently published research and review undertaken by a work group including members of the American Rhinologic Society’s allergy and immunology section and Johns Hopkins climate scientists.

Video

Vocal Care and Rates of Treatment Follow-up for Transgender Voice Patients

Johns Hopkins laryngologist Simon Best summarizes findings from a study that identified factors that help transgender patients follow through with the recommended course of treatment for vocal care.

Video

Pediatric Vestibular Disorders

Pediatric otolaryngologist Carolyn Jenks discusses Johns Hopkins’ multidisciplinary approach to treating dizziness and balance disorders in pediatric patients.

Video

SARS-CoV-2 Infection and Post-Extubation Laryngeal Function

Johns Hopkins Otolaryngologist Kevin Motz recaps a presentation, from the 2021 annual meeting of the AAOHNSF, about research related to the incidence and sequela of intubation related to COVID-19.

Video

Case Presentation: Sinonasal Squamous Cell Carcinoma

Head and neck cancer and skull base surgeon Nyall London describes the case of a patient who presented with a nasal mass that was determined to be human papillomavirus (HPV) positive sinonasal squamous cell carcinoma.

Video

An Innovative Approach to Sciatic Nerve Repair

Neurosurgeon Allan Belzberg, M.D., and orthopaedic trauma surgeon Greg Osgood, M.D., collaborated to offer a novel way to repair the sciatic nerve of a patient.

Video

Current Indications for PD-1/PD-L1 Immunotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Head and neck cancer and skull base surgeon Nyall London discusses three key immunotherapy clinical trials including KEYNOTE-012, Checkmate 141 and KEYNOTE-048 that have contributed to Food and Drug Administration approval for nivolumab ...

Video

Immunotherapy Treats Recurrent Laryngeal Cancer: A Physician and Patient Perspective

Head and neck cancer surgeon Christine Gourin and patient Jerry, who had a recurrence of laryngeal cancer, discuss his long-term response to immunotherapy as part of a clinical trial in which he participated in 2014, a time when research ...